Connection
Susan Apkon to Risk Assessment
This is a "connection" page, showing publications Susan Apkon has written about Risk Assessment.
|
|
Connection Strength |
|
 |
|
 |
|
0.051 |
|
|
|
-
Apkon SD. Osteoporosis in children who have disabilities. Phys Med Rehabil Clin N Am. 2002 Nov; 13(4):839-55.
Score: 0.026
-
Hollin IL, Peay HL, Apkon SD, Bridges JFP. Patient-centered benefit-risk assessment in duchenne muscular dystrophy. Muscle Nerve. 2017 05; 55(5):626-634.
Score: 0.017
-
Oleszek JL, Chang N, Apkon SD, Wilson PE. Botulinum toxin type a in the treatment of children with congenital muscular torticollis. Am J Phys Med Rehabil. 2005 Oct; 84(10):813-6.
Score: 0.008